Primary CNS lymphoma: Treatment with combined chemotherapy and radiotherapy

Journal of Neuro-Oncology

Volumn 43, Issue 3, 1999, Pages 249-257

  DeAngelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Neurotoxicity; Primary CNS lymphoma; Radiotherapy

Indexed keywords

BLEOMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLINIC ACID; HYDROXYUREA; LOMUSTINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

AGE; BRAIN LYMPHOMA; CANCER RECURRENCE; CANCER SURVIVAL; DEMENTIA; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; LYMPHOMA, NON-HODGKIN;

EID: 0032832008     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006258619757     Document Type: Review

References (29)

1. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel F, Burger PC: Increasing incidence of primary brain lymphoma in the US. Cancer 62: 2461-2465, 1988
2. DeAngelis LM: Current management of primary central nervous system lymphoma. Oncology 9: 63-78, 1995
3. DeAngelis LM, Yahalom J, Thaler HT, Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635-643, 1992
4. Reni M, Ferreri AJM, Garancini MP, Villa E: Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8: 227-234, 1997
5. Blay J-Y, Conroy T, Chevreau C, Thyss A, Quesnel, Eghbali, Bouabdallah R, Coiffier B, Wagner J-P, Le Mevel A, Dramais-Marcel D, Baumelou E, Chauvin F, Biron P: High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 6: 864-871, 1998
6. Corry J, Smith JG, Wirth A, Quong, G, Liew KH: Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 41: 615-620, 1998
7. Singh A, Strobos RJ, Singh BM, Rothballer AB, Reddy V, Puljic S, Poon TP: Steroid-induced remission in CNS lymphoma. Neurology 32: 1267-1271, 1982
8. Pirotte B, Levivier M, Goldman S, Brucher J-M, Brotchi J, Hildebrand J: Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature. J Neuro-Oncol 32: 63-69, 1997
9. DeAngelis LM, Yahalom J, Heinemann M-H, Cirrincione C, Thaler HT, Krol G: Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology 40: 80-86, 1990
10. Bleyer WA: Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 65 (Suppl 11): 89-98, 1981
11. Geyer JR, Taylor EM, Milstein JM: Radiation, methotrexate and white matter necrosis: laboratory evidence for neural radioprotection with preirradiation methotrexate. Int J Radiat Oncol Biol Phys 15: 373-375, 1988
12. Fisher RI, Gaynor ER, Dahlaberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA, Miller TP: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New Eng J Med 328: 1002-1006, 1993
13. Lachance DH, Brizel DM, Gockerman JP, Halperin EC, Burger PC, Boyko OB, Brown MT, Schold SC: Cyclophosphamide, doxorubicin, vincristine and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy. Neurology 44: 1721-1727, 1994
14. Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, Fisher B, Abrams R, Meis-Kindblom J: Preirradiation chemotherapy with cyclophosphamide doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 14: 556-564, 1996
15. O'Neill BP, O'Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL: Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Rad Oncol Biol Phys 33: 663-673, 1995
16. Brada M, Dearnaley D, Horwich A, Bloom HJG: Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. Int J Rad Oncol Biol Phys 18: 787-792, 1990
17. Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ: Measurements of blood-brain barrier permeability inpatients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27: 1356-1361, 1991
18. Ervin T, Canellos GP: Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer 45: 1556-1557, 1980
19. Loeffler JS, Ervin TJ, Mauch P, Skarin A, Weinstein HJ, Canellos G, Cassady JR: Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3: 490-494, 1985
20. Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Hotleman K: High-dose methotrexate for non-AIDS primary central nervous system lymphoma report of 13 cases. J Neurosurg 70: 190-194, 1989
21. Glass J, Gruber ML, Cher L, Hochberg FH: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81: 188-195
22. Abrey LE, DeAngelis LM, Yahalom J: Long-term survival in primary central nervous system lymphoma. J Clin Oncol 16: 1-6, 1998
23. DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39: 789-796, 1989
24. Merchut MP, Haberland C, Naheedy MH, Rubino FA: Long survival of primary cerebral lymphoma with progressive radiation necrosis. Neurology 35: 552-556, 1985
25. Chamberlain MC, Levin VA: Primary central nervous system lymphoma: a role for adjuvant chemotherapy. J Neuro-Oncol 14: 271-275, 1992
26. Cher L, Glass J, Harsh GR, Hochberg FH. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 46: 1757-1759, 1996
27. Freilich RJ, Delattre J-Y, Monjour A, DeAngelis LM: Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46: 435-439, 1996
28. Dahlborg SA, Henner WD, Crossen JR, Tableman M, Petrillo A, Braziel R, Neuwelt EA: Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhances chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am 2: 166-174, 1996
29. Sandor V, Stark-Vanes V, Pearson D, Nussenblat R, Whitcup SM, Brouwers P, Patronas N, Heiss J, Jaffe E, deSmet M, Kohler D, Simon R, Wittes R: Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 16: 3000-3006, 1998